Answer
Concomitant esomeprazole decreases pazopanib bioavailability by approximately 40%, measured by AUC and Cmax.
Sources for this answer
- Pazopanib 200 mg film-coated tabletsDr. Reddy's Laboratories (UK) Ltd · emc · SmPC §4.5 Interaction with other medicinal products · Version 1Document updated
Sources checked